OPT

Opthea (OPT)

Opthea Ltd

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:OPT

1 2 3 4 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/28	19:05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:OPT	Opthea Ltd
2024/02/14	20:07	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:OPT	Opthea Ltd
2024/02/01	20:04	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:OPT	Opthea Ltd
2024/01/11	20:01	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:OPT	Opthea Ltd
2023/12/27	20:01	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:OPT	Opthea Ltd
2023/12/27	20:00	GlobeNewswire Inc.	Opthea to Receive US$35M Commitment and Additional US$50M Funding	NASDAQ:OPT	Opthea Ltd
2023/12/19	20:00	GlobeNewswire Inc.	Opthea Receives A$8.8 million R&D Tax Incentive	NASDAQ:OPT	Opthea Ltd
2023/12/01	19:30	GlobeNewswire Inc.	Opthea to Present at the FLORetina 2023 Congress	NASDAQ:OPT	Opthea Ltd
2023/11/09	20:01	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:OPT	Opthea Ltd
2023/11/09	19:30	GlobeNewswire Inc.	Opthea to Present at the Jefferies 2023 London Healthcare Conference	NASDAQ:OPT	Opthea Ltd
2023/10/30	18:30	GlobeNewswire Inc.	Opthea to Present at Eyecelerator Forum at the 2023 American Academy of Ophthalmology (AAO) Conference	NASDAQ:OPT	Opthea Ltd
2023/10/27	19:09	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:OPT	Opthea Ltd
2023/10/27	19:06	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:OPT	Opthea Ltd
2023/10/27	18:30	GlobeNewswire Inc.	Opthea Appoints U.S.-Based Leadership with Fred Guerard as CEO and Peter Lang as CFO	NASDAQ:OPT	Opthea Ltd
2023/10/02	18:30	GlobeNewswire Inc.	Opthea to Participate at the 2023 Euretina Congress	NASDAQ:OPT	Opthea Ltd
2023/09/07	19:04	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:OPT	Opthea Ltd
2023/09/07	18:30	GlobeNewswire Inc.	Opthea to Present at the H.C. Wainwright 25th Annual Global Investment Conference	NASDAQ:OPT	Opthea Ltd
2023/08/28	19:15	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:OPT	Opthea Ltd
2023/08/28	18:30	GlobeNewswire Inc.	Opthea Successfully Completes Institutional Offer and Increases Capital Raising to A$90.0m (US$57.6 million¹)	NASDAQ:OPT	Opthea Ltd
2023/08/24	19:16	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:OPT	Opthea Ltd
2023/08/01	19:01	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:OPT	Opthea Ltd
2023/07/26	19:00	GlobeNewswire Inc.	Opthea Announces “Sozinibercept” as the Nonproprietary Drug Name for OPT-302	NASDAQ:OPT	Opthea Ltd
2023/07/24	19:01	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:OPT	Opthea Ltd
2023/07/24	19:00	GlobeNewswire Inc.	Opthea to Present at the 2023 Ophthalmology Innovation Summit	NASDAQ:OPT	Opthea Ltd
2023/07/13	19:02	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:OPT	Opthea Ltd
2023/07/13	19:00	GlobeNewswire Inc.	Opthea to Feature at the American Society of Retina Specialists 2023 Annual Meeting	NASDAQ:OPT	Opthea Ltd
2023/07/10	19:00	GlobeNewswire Inc.	Opthea Announces Departure of Chief Medical Officer and Appointment of Senior Medical Advisor	NASDAQ:OPT	Opthea Ltd
2023/06/08	19:03	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:OPT	Opthea Ltd
2023/06/08	19:00	GlobeNewswire Inc.	Opthea Appoints Anshul Thakral as Non-Executive Director of the Board	NASDAQ:OPT	Opthea Ltd
2023/05/25	21:00	PR Newswire (Canada)	Optiva and lifecell Named as a Nominee in TM Forum's 16th Annual Excellence Awards	NASDAQ:OPT	Opthea Ltd